A benefit for South Lake Tahoe local Jennifer Milligin, who is recovering from Ocular Melanoma (eye cancer), will be held at ...

Morning Pointe Senior Living announces Fred Hutagaol has been selected as the recipient of the Morning Pointe Scholars Endowment scholarship at Southern Adventist University. “The Morning ... more ...

Join the Miami Dolphins for a fundraising ride, run and walk in support of innovative cancer research this month at Hard Rock ...

Hundreds of people are diagnosed with eye cancer in the UK every year but it often goes unnoticed with symptoms dismissed ...

Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, ...

Now aged two, Flynn, from Wigston in Leicestershire, went through months of chemotherapy and laser therapy to treat a rare ...

According to Cancer Research UK, around 880 people in the UK are diagnosed with ocular cancer each year, with approximately 130 losing their lives to the disease. Despite its rarity, accounting for ...

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy by targeting key immune pathways such as PD-1, PD-L1, CTLA-4, and LAG-3 to enhance the immune system's ability to combat ...

No, glaucoma isn’t cancer. It’s a chronic eye condition that may lead to blurry vision and vision loss due to damage to the optic nerve. Glaucoma results from the pressure caused by fluid ...

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Among changes eye specialists have highlighted are blurred vision and eye irritation that doesn't respond to standard treatments — which many people put down to staring at screens for too long.